Category: Treatment - CBT

PS4- #A17 - CBT for Perinatal Anxiety: Preliminary Data From a Randomized Controlled Trial

Friday, Nov 17
12:15 PM – 1:15 PM
Location: Indigo Ballroom CDGH, Level 2, Indigo Level

Keywords: Adult Anxiety | Treatment-CBT | Pregnancy / Postpartum / Reproductive Issues

Background: The perinatal period (i.e., pregnancy and the first 12 months postpartum) is a time of many biological, psychological and social changes in a woman’s life. Although this period can be exciting, a significant proportion of women experience clinically elevated levels of distress (Matthey et al., 2003). To date, cognitive behaviour therapy (CBT) protocols have primarily been developed to target depressive symptoms among women during pregnancy or the postpartum. Recent evidence suggests, however, that anxiety symptoms or anxiety disorders are at least as prevalent, if not more so, than mood disorders during this time (Goodman et al., 2014) and effective treatment is essential.

Goals and Hypotheses:
To address this gap in the literature, we developed a new CBT protocol designed specifically to target the worry and anxiety symptoms commonly reported by women during pregnancy and in the postpartum period. Recent pilot data (Green et al., 2013) supports the effectiveness of this CBT protocol in treating anxiety and mood symptoms in this population. A larger RCT is now underway with an expected sample of N = 30 participants by October 2017. Preliminary data from this 2-year RCT will be presented. It is hypothesized that, when compared to a waitlist condition, CBT will be associated with greater reductions in (1) worry and anxiety and (2) in co-occurring depressive symptoms by posttreatment. Finally, (3) it is hypothesized that treatment gains will be maintained at 3-months following treatment. Participant satisfaction with the treatment protocol will also be evaluated.

Method and
Results:
Participants are being recruited from the Women’s Health Concerns Clinic, St. Joseph Healthcare Hamilton, which is an outpatient program in an academic hospital. Participants are randomized to a 6-week group CBT intervention for perinatal anxiety (Green et al., 2013) or a 6-week waitlist control condition. Self-report symptom measures are administered at pre and posttreatment. Satisfaction with treatment is assessed following treatment. The impact of CBT on symptom variables will be assessed with a series of mixed-effects ANOVA analyses.


Conclusion:
This study will provide an initial validation of a new CBT intervention for women who are experiencing clinically significant symptoms of anxiety during the perinatal period.

Sheryl M. Green

McMaster University
Toronto, Canada

Eleanor Donegan

Post-Doctoral Fellow
St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada

Benicio Frey

McMaster University

Arela Agako

MSc Student
McMaster University

Randi E. McCabe

McMaster University
Hamilton, Ontario, Canada